Trial · NCT02138006
Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes
NCT02138006, Not applicable, Completed, Karolinska Institutet; results first posted 2015-12-21
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes. Trials, record NCT02138006. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02138006
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes
- NCT number
- NCT02138006
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 102 participants, actual
- Lead sponsor
- Karolinska Institutet
- Conditions
- Coronary Heart Disease, Stroke, Renal Failure
- Interventions
- Intensive insulin treatment, Standard insulin treatment
- First posted
- 2014-05-14
- Last updated
- 2016-10-24
- Results first posted
- 2015-12-21
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cardiovascular Mortality | Up to 28 years | All cause mortality and composite mortality from myocardial infarction, stroke and renal failure |
| Secondary | Morbidity of Cardiovascular Complications | Up to 28 years | Morbidity of: coronary heart disease, stroke and renal failure |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Cardiovascular Mortality | Up to 28 years | participants | NUMBER | |
| SECONDARY | Morbidity of Cardiovascular Complications | Up to 28 years | participants | NUMBER |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Cardiovascular Mortality | Intensive Insulin Treatment | 7 | participants | ||
| Cardiovascular Mortality | Standard Insulin Treatment | 11 | participants | ||
| Morbidity of Cardiovascular Complications | Intensive Insulin Treatment | 6 | participants | ||
| Morbidity of Cardiovascular Complications | Standard Insulin Treatment | 11 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Intensive Insulin Treatment | 48 | |
| Overall Study | STARTED | Standard Insulin Treatment | 54 | |
| Overall Study | COMPLETED | Intensive Insulin Treatment | 48 | |
| Overall Study | COMPLETED | Standard Insulin Treatment | 54 | |
| Overall Study | NOT COMPLETED | Intensive Insulin Treatment | 0 | |
| Overall Study | NOT COMPLETED | Standard Insulin Treatment | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Intensive Insulin Treatment | ||
| Total, all-cause mortality | Standard Insulin Treatment | ||
| Total, other adverse events | Intensive Insulin Treatment | 0 | 48 |
| Total, other adverse events | Standard Insulin Treatment | 0 | 54 |
| Total, serious adverse events | Intensive Insulin Treatment | 0 | 48 |
| Total, serious adverse events | Standard Insulin Treatment | 0 | 54 |
Source ClinicalTrials.gov
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Intensive Insulin Treatment vs Standard Insulin Treatment: Cardiovascular Mortality | Trial comparisons |
| Intensive Insulin Treatment vs Standard Insulin Treatment: Morbidity of Cardiovascular Complications | Trial comparisons |
| Intensive Insulin Treatment vs Standard Insulin Treatment: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02138006
GET https://conductscience.org/api/trials/v1/NCT02138006/registered